Novartis Can't Duck Elidel FCA Suit, But Kickback Claims Cut

Law360, New York (June 14, 2013, 4:38 PM EDT) -- A Pennsylvania federal judge on Thursday refused to dismiss a former Novartis Pharmaceuticals Corp. employee's whistleblower lawsuit, which accuses the drugmaker of ripping off Medicaid by promoting off-label uses of eczema treatment Elidel, but stripped anti-kickback claims from the suit.

Judge Gene E.K. Pratter rejected most of Novartis's 295-page motion to dismiss, but agreed that claims based on kickback allegations could not survive based on the first-to-file rule. As a whole, the decision allows former Novartis senior sales consultant Donald R. Galmines to proceed with his...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.